LCN2 and urogenital neoplasm: Utilizing this protocol, they were able to show that both Neutrophil gelatinase-associated lipocalin (NGAL) which is an early biomarker for ischemic, septic, or nephrotoxic kidney injury, expressed in both thick ascending limb and collecting duct and HAVCR1, a biomarker for PT injury, were upregulated following treatment with cisplatin in a cell specific manner.